I. Dogan Et Al. , "Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib," JOURNAL OF THORACIC ONCOLOGY , vol.16, no.4, 2021
Dogan, I. Et Al. 2021. Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib. JOURNAL OF THORACIC ONCOLOGY , vol.16, no.4 .
Dogan, I., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydin, E., Vatansever, S., ... Saip, P.(2021). Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib. JOURNAL OF THORACIC ONCOLOGY , vol.16, no.4.
Dogan, I. Et Al. "Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib," JOURNAL OF THORACIC ONCOLOGY , vol.16, no.4, 2021
Dogan, I. Et Al. "Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib." JOURNAL OF THORACIC ONCOLOGY , vol.16, no.4, 2021
Dogan, I. Et Al. (2021) . "Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib." JOURNAL OF THORACIC ONCOLOGY , vol.16, no.4.
@article{article, author={I. Dogan Et Al. }, title={Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib}, journal={JOURNAL OF THORACIC ONCOLOGY}, year=2021}